[Empa-reg and leader trials -revolution in modern diabetology?]

Lijec Vjesn. 2016 Jan-Feb;139(1-2):45-6.
[Article in Croatian]
No abstract available

Publication types

  • Editorial

MeSH terms

  • Cardiovascular Diseases / prevention & control*
  • Diabetes Mellitus, Type 2 / drug therapy*
  • Humans
  • Hypoglycemic Agents / pharmacology*
  • Randomized Controlled Trials as Topic

Substances

  • Hypoglycemic Agents